Pressreleases

Gerresheimer supplies PET bottles for urgently needed hand sanitizer

Gerresheimer is currently working flat out to produce a high number of PET bottles so that they can be filled with the required disinfectant and supplied to recipients.

New Tools and Models Designed to Optimise Costs and Protect the Environment

Predict, anticipate, for better selection. Reuse to protect and make savings.

Enamine and Chemspace Collaborate with Blue Dolphin Lead Discovery to Expand Drug Discovery Services

Enamine, a leading provider of small molecules and drug discovery services, Chemspace, an online catalog with the largest offer of

Vetter’s High Performance is Again Recognised at the 2020 CMO Leadership Awards

A win in all six core categories reaffirms Vetter as a trusted solution provider.

Remote and Virtual GMP Audits From NSF

Due to the current climate and imposed travel restrictions it can be difficult to carry out the necessary GMP inspections

Porton Biopharma Limited Licenses Erwinase® to Clinigen

Porton Biopharma Limited (PBL), the UK biopharmaceutical research, development and manufacturing company, announces that it has signed an exclusive, worldwide licensing agreement with Clinigen for the distribution of Erwinase®/ Erwinaze®, the company’s life-saving treatment for acute lymphoblastic leukaemia, a cancer of the blood predominantly affecting children.

SGS Donates PPE and Offers Beds and Staff to ZNA Stuivenberg Hospital, Antwerp, Belgium

SGS is supporting ZNA Stuivenberg Hospital, Antwerp in its fight against the COVID-19 pandemic.

eLearning and Virtual Training from NSF

Complimentary Data Integrity eLearning NSF is offering free access to their Data Integrity eLearning until April 30, 2020. Written and

SGS Digicomply Launches COVID-19 INTEL – an AI Platform for Teams on the Pandemic Research Frontline

As medical research teams around the world accelerate their efforts to combat the COVID-19 pandemic, SGS Digicomply has launched a complimentary, new AI tool to facilitate and enhance their pioneering work – COVID-19 INTEL.